1,739
Views
3
CrossRef citations to date
0
Altmetric
Cardiovascular

Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US

, , , , , & show all
Pages 1365-1374 | Received 07 Aug 2020, Accepted 03 Sep 2020, Published online: 29 Sep 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.